Bio
David B. Samadi, MD, is the Vice Chairman, Department of Urology and Chief of Robotics and Minimally Invasive Surgery at The Mount Sinai Medical Center in New York City.
Dr. Samadi is one of the very few urologic surgeons in the United States trained in oncology, open, laparoscopic, and robotic surgery. To date, Dr. Samadi has performed over 3,500 robotic laparoscopic prostate surgeries, and the results are very pleasing for his patients. Additionally, over the past seven years, Dr. Samadi has been actively involved in training and proctoring urologists across the country and internationally.
A board-certified urologist, Dr. Samadi is a specialist in the diagnosis and treatment of urologic diseases, kidney cancer, bladder cancer, and prostate cancer. He performs many advanced minimally invasive treatments for prostate cancer, including laparoscopic radical prostatectomy and laparoscopic robotic radical prostatectomy.
Robotic Prostatectomy Expertise
Dr. Samadi is one of the few surgeons in New York State qualified to perform a robotic prostatectomy, using the da Vinci robotic system. He is the first surgeon in the United States to successfully perform a robotic surgery redo, demonstrating his mastery of the da Vinci robotic system and proven ability to medically help patients with low and high risks of prostate cancer.
He completed his post graduate training in general surgery at Montefiore Medical Center and in urology at Albert Einstein School of Medicine and Montefiore Medical Center. He went on to do an oncology fellowship in urology at Memorial Sloan Kettering Cancer Center and a robotic radical prostatectomy fellowship at Henri Mondor Hospital Creteil in France under the mentorship of Professor Claud Abbou.
Dr. Samadi is a member of the American Urologic Association and the American Medical Association.
Director of Robotic Fellowship Program
Dr. Samadi is Founder and Director of Mount Sinai's Robotic Fellowship Program. The Program is dedicated to clinical and surgical excellence by providing exceptional opportunities for doctors who have completed their residency to train directly with Dr. Samadi. Fellows typically will spend a year working as a full-time, paid assistant to Dr. Samadi. However, all surgeries are performed by Dr. Samadi from beginning to end. Fellowships are awarded based on merit, along with potential to contribute to the fields of urology, oncology, and minimally invasive surgery.
The Robotic Fellowship Program has three components: medical research, clinical training with an emphasis on robotic, laparoscopic, and renal surgical methods, and treatment of urological diseases, which includes prostate, bladder, and kidney cancers.
Dr. Samadi frequently presents his clinical research at medical conferences as a subject matter expert nationally and internationally. His website, http://www.RoboticOncology.com, has been translated into six different languages and is one of the most popular urology sites on the Internet.
Dr. Samadi is one of the very few urologic surgeons in the United States trained in oncology, open, laparoscopic, and robotic surgery. To date, Dr. Samadi has performed over 3,500 robotic laparoscopic prostate surgeries, and the results are very pleasing for his patients. Additionally, over the past seven years, Dr. Samadi has been actively involved in training and proctoring urologists across the country and internationally.
A board-certified urologist, Dr. Samadi is a specialist in the diagnosis and treatment of urologic diseases, kidney cancer, bladder cancer, and prostate cancer. He performs many advanced minimally invasive treatments for prostate cancer, including laparoscopic radical prostatectomy and laparoscopic robotic radical prostatectomy.
Robotic Prostatectomy Expertise
Dr. Samadi is one of the few surgeons in New York State qualified to perform a robotic prostatectomy, using the da Vinci robotic system. He is the first surgeon in the United States to successfully perform a robotic surgery redo, demonstrating his mastery of the da Vinci robotic system and proven ability to medically help patients with low and high risks of prostate cancer.
He completed his post graduate training in general surgery at Montefiore Medical Center and in urology at Albert Einstein School of Medicine and Montefiore Medical Center. He went on to do an oncology fellowship in urology at Memorial Sloan Kettering Cancer Center and a robotic radical prostatectomy fellowship at Henri Mondor Hospital Creteil in France under the mentorship of Professor Claud Abbou.
Dr. Samadi is a member of the American Urologic Association and the American Medical Association.
Director of Robotic Fellowship Program
Dr. Samadi is Founder and Director of Mount Sinai's Robotic Fellowship Program. The Program is dedicated to clinical and surgical excellence by providing exceptional opportunities for doctors who have completed their residency to train directly with Dr. Samadi. Fellows typically will spend a year working as a full-time, paid assistant to Dr. Samadi. However, all surgeries are performed by Dr. Samadi from beginning to end. Fellowships are awarded based on merit, along with potential to contribute to the fields of urology, oncology, and minimally invasive surgery.
The Robotic Fellowship Program has three components: medical research, clinical training with an emphasis on robotic, laparoscopic, and renal surgical methods, and treatment of urological diseases, which includes prostate, bladder, and kidney cancers.
Dr. Samadi frequently presents his clinical research at medical conferences as a subject matter expert nationally and internationally. His website, http://www.RoboticOncology.com, has been translated into six different languages and is one of the most popular urology sites on the Internet.
Online: